GILEAD SCIENCES, INC.

GILD

GILEAD SCIENCES, INC.

GILD

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-06-15Shares Purchased (TTM):0Shares Sold (TTM):576,731

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:973,233,293Shares Outstanding:1,242,000,000Institutional Ownership Pct.:78.36%

Earnings Market Reaction:

Filing Date:2026-05-07Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Biological Products, (No Diagnostic Substances)

AMGN SCLX BIIB MRNA RVMD NBIX

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	7,628	7,564	7,330	5,144	7,926	9,991	5,037	2,772	4,718	6,085	5,705	5,704
Marketable Securities Current	15	68	19	69	-	0	0	0	0	1,179	1,159	963
Accounts Receivable Net Current	4,741	4,913	5,095	4,781	4,388	4,420	4,587	4,663	4,669	4,660	4,790	4,229
Inventory Net	1,914	1,774	1,785	1,825	1,759	1,710	1,869	2,026	1,853	1,787	1,663	1,633
Prepaid Expense And Other Assets Current	4,342	4,024	3,645	2,899	2,828	3,052	3,287	2,856	2,800	2,374	2,662	1,757
Assets Current	18,641	18,342	17,874	14,718	16,901	19,173	14,779	12,317	14,041	16,085	15,980	14,287
Property Plant And Equipment Net	5,638	5,606	5,500	5,459	5,421	5,414	5,391	5,346	5,321	5,317	5,572	5,540
Marketable Securities Noncurrent	983	2,974	2,005	1,913	-	0	0	0	0	1,163	1,156	1,334
Intangible Assets Net Excluding Goodwill	16,382	16,978	17,970	18,566	19,355	19,948	20,546	22,832	23,428	26,454	27,152	27,750
Goodwill	8,314	8,314	8,314	8,314	8,314	8,314	8,314	8,314	8,314	8,314	8,314	8,314
Deferred Income Tax Assets Net	1,767	1,964	1,998	2,721	2,572	2,378	-	-	-	-	-	-
Other Assets Noncurrent	4,554	4,845	4,873	4,031	3,871	3,769	5,494	4,770	5,188	4,792	4,200	5,113
Assets	56,278	59,023	58,533	55,721	56,434	58,995	54,525	53,579	56,292	62,125	62,373	62,337
Liabilities Current
Accounts Payable Current	645	715	808	582	737	833	903	537	622	550	586	622
Debt Current	1,313	2,807	2,806	2,806	2,806	1,815	1,812	1,810	3,667	1,798	1,793	4,037
Other Liabilities Current	3,399	3,953	3,752	3,586	4,615	5,464	4,896	4,510	4,464	5,130	5,852	5,810
Liabilities Current	9,476	11,813	12,298	11,189	12,344	12,004	11,725	10,781	13,015	11,280	11,945	13,964
Long Term Debt Noncurrent	20,861	22,129	22,135	22,140	22,146	24,896	21,437	21,540	21,527	23,189	23,189	21,209
Accrued Income Taxes Noncurrent	918	896	866	859	819	830	782	738	1,967	2,039	2,088	2,610
Deferred Income Tax Liabilities Net	392	402	597	652	709	724	794	907	933	1,588	1,984	2,106
Other Liabilities Noncurrent	1,200	1,165	1,182	1,290	1,337	1,295	1,396	1,418	1,395	1,280	924	1,354
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	1	1	1	1	1	1	1	1	1	1	1	1
Additional Paid In Capital	9,305	8,932	8,678	8,367	8,138	7,700	7,327	7,022	6,813	6,500	6,279	6,008
Accumulated Other Comprehensive Income Loss Net Of…	78	39	36	-18	92	132	73	93	69	28	31	10
Retained Earnings Accumulated Deficit	14,131	13,730	12,825	11,325	10,931	11,497	11,073	11,165	10,656	16,304	16,002	15,138
Stockholders Equity	23,515	22,703	21,456	19,590	19,162	19,330	18,390	18,197	17,455	22,833	22,242	21,158
Minority Interest	-84	-84	-84	-84	-84	-84	-84	-84	-84	-84	-72	-64
Liabilities And Stockholders Equity	56,278	59,023	58,533	55,721	56,434	58,995	54,525	53,579	56,292	62,125	62,373	62,337
Liabilities And Stockhold…
Stockholders Equity Inclu…
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Preferred Stock Shares Authorized	5	5	5	5	5	5	5	5	5	5	5	5
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	5,600	5,600	5,600	5,600	5,600	5,600	5,600	5,600	5,600	5,600	5,600	5,600
Common Stock Shares Issued	1,242	1,241	1,242	1,242	1,245	1,246	1,246	1,246	1,246	1,246	1,247	1,247
Shares Outstanding	1,242	1,241	1,242	1,242	1,245	1,246	1,246	1,246	1,246	1,246	1,247	1,247

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	0.28%	-3.98%	-2.91%	-	-	-	-	-	-	-	-	-
2025	11.30%	12.70%	18.33%	2.44%	2.36%	10.43%	5.89%	5.62%	15.14%	-6.54%	-6.24%	-11.73%
2024	-1.00%	6.98%	20.08%	4.51%	11.64%	18.84%	-2.35%	-2.30%	3.89%	-5.67%	-7.91%	-9.70%
2023	-	-	-	-2.31%	-3.73%	-0.15%	-3.67%	1.41%	-0.45%	1.22%	-6.50%	-9.40%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	1.97	1.55	1.45	1.32	1.37	1.60	1.26	1.14	1.08	1.43	1.34	1.02
Quick Ratio	1.31	1.06	1.01	0.89	1.00	1.20	0.82	0.69	0.72	1.06	0.98	0.78
Working Capital	9.17B	6.53B	5.58B	3.53B	4.56B	7.17B	3.05B	1.54B	1.03B	4.81B	4.04B	323.00M
Leverage & Debt
Debt to Equity	0.40	0.52	0.57	0.57	0.64	0.62	0.64	0.59	0.75	0.50	0.54	0.66
Interest Coverage TTM	10.33	9.79	10.30	8.05	8.36	1.70	0.57	1.78	1.11	5.42	9.00	9.26
Debt Ratio	0.17	0.20	0.21	0.20	0.22	0.20	0.22	0.20	0.23	0.18	0.19	0.22
Efficiency & Turnover
Asset Turnover TTM	0.53	0.50	0.51	0.53	0.51	0.47	0.48	0.48	0.46	0.43	0.44	0.44
Days Sales Outstanding TTM	56.03	57.85	60.75	59.71	57.52	57.63	60.47	58.36	58.71	63.51	60.92	55.63
Receivables Turnover TTM	6.51	6.31	6.01	6.11	6.35	6.33	6.04	6.25	6.22	5.75	5.99	6.56
Per Share Metrics
Diluted EPS TTM	7.35	6.78	6.47	5.03	4.74	0.38	0.11	0.85	0.39	4.50	4.67	4.35
Free Cash Flow Per Share TTM	8.24	7.60	7.37	7.53	7.90	8.26	7.56	5.53	6.34	5.95	6.29	7.15
Dividend Per Share TTM	3.25	3.22	3.20	3.18	3.16	3.14	3.12	3.09	3.07	3.05	3.03	3.01
Margin Metrics
Gross Profit Margin TTM	79.35%	78.83%	78.72%	78.53%	78.29%	78.26%	76.11%	75.72%	75.78%	76.04%	78.81%	79.42%
Operating Profit Margin TTM	34.88%	34.04%	36.06%	27.89%	28.61%	5.78%	2.90%	9.20%	5.75%	28.05%	30.16%	30.95%
Net Profit Margin TTM	30.99%	28.90%	27.88%	21.87%	20.76%	1.67%	0.47%	3.81%	1.77%	20.89%	21.43%	20.01%
Growth Metrics
Net Revenue Growth (1Y)	3.48%	2.40%	2.78%	3.81%	4.68%	6.04%	3.31%	1.54%	1.51%	-0.60%	0.94%	-0.48%
Net Income Growth (1Y)	54.50%	1,672.92%	5,997.74%	495.38%	1,129.90%	-91.53%	-97.73%	-80.65%	-91.31%	23.37%	75.77%	32.25%
EPS Growth (1Y)	55.00%	1,677.19%	6,017.37%	496.33%	1,130.88%	-91.52%	-97.73%	-80.62%	-91.31%	24.06%	76.76%	33.00%
Valuation Metrics
P/E TTM	18.66	17.72	16.70	21.32	22.65	230.61	749.12	76.21	175.66	16.48	14.58	15.92
P/B TTM	7.31	6.67	6.31	6.87	7.05	5.75	5.42	4.44	4.88	4.10	3.85	4.12
P/S TTM	5.78	5.12	4.66	4.66	4.70	3.85	3.52	2.91	3.10	3.44	3.12	3.19
Market Cap	171.97B	150.84B	135.40B	134.53B	135.11B	110.69B	99.63B	80.78B	85.20B	93.34B	85.57B	87.22B
Enterprise Value	186.51B	168.21B	153.01B	154.33B	152.14B	127.41B	117.85B	101.36B	105.67B	112.24B	104.85B	106.76B
Calculated Values
Free Cash Flow TTM	10.23B	9.46B	9.16B	9.37B	9.84B	10.31B	9.43B	6.90B	7.90B	7.42B	7.85B	8.93B
Net Debt	14.55B	17.37B	17.61B	19.80B	17.03B	16.72B	18.21B	20.58B	20.48B	18.90B	19.28B	19.54B
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-15Sale

Owner: Mercier, Johanna

Title: Chief Comm & Corp Aff Officer

Shares: 3,000

Price/Share: $124.27

Value: $372,810.00

Shares Owned: 124,234

Relationship: Officer

Ownership: Direct

2026-06-15Sale

Owner: Dickinson, Andrew D

Title: Chief Financial Officer

Shares: 3,000

Price/Share: $125.40

Value: $376,200.00

Shares Owned: 171,646

Relationship: Officer

Ownership: Direct

2026-06-01Sale

Owner: O'Day, Daniel Patrick

Title: Chairman & CEO

Shares: 15,000

Price/Share: $132.10

Value: $1,981,500.00

Shares Owned: 617,567

Relationship: Director,Officer

Ownership: Direct

2026-05-15Sale

Owner: Mercier, Johanna

Title: Chief Comm & Corp Aff Officer

Shares: 28,000

Price/Share: $131.62

Value: $3,685,360.00

Shares Owned: 125,779

Relationship: Officer

Ownership: Direct

2026-05-15Sale

Owner: Dickinson, Andrew D

Title: Chief Financial Officer

Shares: 3,000

Price/Share: $132.27

Value: $396,810.00

Shares Owned: 173,191

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-15	Mercier, Johanna	Officer	Chief Comm & Corp Aff Officer	Direct	Sale	3,000	124.27	$372,810.00	124,234	4
2026-06-15	Dickinson, Andrew D	Officer	Chief Financial Officer	Direct	Sale	3,000	125.40	$376,200.00	171,646	4
2026-06-01	O'Day, Daniel Patrick	Director,Officer	Chairman & CEO	Direct	Sale	15,000	132.10	$1,981,500.00	617,567	4
2026-05-15	Mercier, Johanna	Officer	Chief Comm & Corp Aff Officer	Direct	Sale	28,000	131.62	$3,685,360.00	125,779	4
2026-05-15	Dickinson, Andrew D	Officer	Chief Financial Officer	Direct	Sale	3,000	132.27	$396,810.00	173,191	4
2026-04-28	O'Day, Daniel Patrick	Director,Officer	Chairman & CEO	Direct	Sale	10,000	129.40	$1,294,000.00	632,567	4
2026-04-15	Mercier, Johanna	Officer	Chief Comm & Corp Aff Officer	Direct	Sale	3,000	140.96	$422,880.00	128,779	4
2026-04-15	Dickinson, Andrew D	Officer	Chief Financial Officer	Direct	Sale	3,000	140.96	$422,880.00	176,191	4
2026-03-27	O'Day, Daniel Patrick	Director,Officer	Chairman & CEO	Direct	Sale	10,000	136.82	$1,368,200.00	642,567	4
2026-03-16	Dickinson, Andrew D	Officer	Chief Financial Officer	Direct	Sale	3,000	144.23	$432,690.00	179,191	4
2026-03-16	Mercier, Johanna	Officer	Chief Comm & Corp Aff Officer	Direct	Sale	3,000	144.23	$432,690.00	131,779	4
2026-02-27	O'Day, Daniel Patrick	Director,Officer	Chairman & CEO	Direct	Sale	10,000	144.98	$1,449,800.00	642,308	4
2026-02-17	Dickinson, Andrew D	Officer	Chief Financial Officer	Direct	Sale	3,000	154.43	$463,290.00	167,779	4
2026-02-17	Mercier, Johanna	Officer	Chief Comm & Corp Aff Officer	Direct	Sale	28,000	154.90	$4,337,200.00	120,288	4
2026-02-05	O'Day, Daniel Patrick	Director,Officer	Chairman & CEO	Direct	Sale	115,640	150.00	$17,346,000.00	613,912	4
2026-01-28	O'Day, Daniel Patrick	Director,Officer	Chairman & CEO	Direct	Sale	10,000	139.89	$1,398,900.00	556,698	4
2026-01-23	O'Day, Daniel Patrick	Director,Officer	Chairman & CEO	Direct	Sale	115,640	135.00	$15,611,400.00	566,698	4
2026-01-20	Bluestone, Jeffrey	Director	-	Direct	Sale	5,000	123.50	$617,500.00	8,920	4
2026-01-15	Mercier, Johanna	Officer	Chief Commercial Officer	Direct	Sale	3,000	124.31	$372,930.00	103,221	4
2026-01-15	Dickinson, Andrew D	Officer	Chief Financial Officer	Direct	Sale	3,000	124.31	$372,930.00	150,503	4
2025-12-29	O'Day, Daniel Patrick	Director,Officer	Chairman & CEO	Direct	Sale	10,000	124.83	$1,248,300.00	566,698	4
2025-12-15	Dickinson, Andrew D	Officer	Chief Financial Officer	Direct	Sale	3,000	122.00	$366,000.00	153,503	4
2025-12-15	Mercier, Johanna	Officer	Chief Commercial Officer	Direct	Sale	3,000	122.00	$366,000.00	106,221	4
2025-11-28	O'Day, Daniel Patrick	Director,Officer	Chairman & CEO	Direct	Sale	10,000	126.38	$1,263,800.00	571,203	4
2025-11-28	Bluestone, Jeffrey	Director	-	Direct	Sale	5,000	125.08	$625,400.00	8,920	4
2025-11-28	Kramer, Kelly A.	Director	-	Direct	Sale	2,805	127.10	$356,515.50	1,339	4
2025-11-17	Mercier, Johanna	Officer	Chief Commercial Officer	Direct	Sale	28,000	126.04	$3,529,120.00	107,193	4
2025-11-17	Dickinson, Andrew D	Officer	Chief Financial Officer	Direct	Sale	2,500	125.23	$313,075.00	154,555	4
2025-11-12	Telman, Deborah H	Officer	EVP, Corporate Affairs & GC	Direct	Sale	53,646	123.07	$6,602,213.22	43,676	4
2025-10-28	O'Day, Daniel Patrick	Director,Officer	Chairman & CEO	Direct	Sale	10,000	119.18	$1,191,800.00	581,203	4
2025-10-15	Mercier, Johanna	Officer	Chief Commercial Officer	Direct	Sale	3,000	118.08	$354,240.00	110,193	4
2025-10-15	Dickinson, Andrew D	Officer	Chief Financial Officer	Direct	Sale	2,500	118.08	$295,200.00	157,055	4
2025-09-29	O'Day, Daniel Patrick	Director,Officer	Chairman & CEO	Direct	Sale	10,000	111.94	$1,119,400.00	591,203	4
2025-09-15	Dickinson, Andrew D	Officer	Chief Financial Officer	Direct	Sale	2,500	113.57	$283,925.00	159,555	4
2025-09-15	Mercier, Johanna	Officer	Chief Commercial Officer	Direct	Sale	3,000	113.57	$340,710.00	113,193	4
2025-08-28	O'Day, Daniel Patrick	Director,Officer	Chairman & CEO	Direct	Sale	10,000	113.63	$1,136,300.00	595,725	4
2025-08-15	Mercier, Johanna	Officer	Chief Commercial Officer	Direct	Sale	28,000	118.74	$3,324,720.00	114,168	4
2025-08-15	Dickinson, Andrew D	Officer	Chief Financial Officer	Direct	Sale	2,500	118.53	$296,325.00	160,110	4
2025-07-28	O'Day, Daniel Patrick	Director,Officer	Chairman & CEO	Direct	Sale	10,000	113.63	$1,136,300.00	605,725	4
2025-07-15	Mercier, Johanna	Officer	Chief Commercial Officer	Direct	Sale	3,000	111.03	$333,090.00	117,168	4
2025-07-15	Dickinson, Andrew D	Officer	Chief Financial Officer	Direct	Sale	2,500	111.03	$277,575.00	162,610	4
2025-07-14	Bluestone, Jeffrey	Director	-	Direct	Sale	5,000	109.74	$548,700.00	8,920	4
2025-06-30	O'Day, Daniel Patrick	Director,Officer	Chairman & CEO	Direct	Sale	10,000	110.78	$1,107,800.00	615,725	4
2025-06-16	Mercier, Johanna	Officer	Chief Commercial Officer	Direct	Sale	3,000	110.17	$330,510.00	120,168	4
2025-06-16	Dickinson, Andrew D	Officer	Chief Financial Officer	Direct	Sale	2,500	110.17	$275,425.00	165,110	4
2025-05-30	O'Day, Daniel Patrick	Director,Officer	Chairman & CEO	Direct	Sale	10,000	110.54	$1,105,400.00	620,268	4
2025-05-22	Mercier, Johanna	Officer	Chief Commercial Officer	Direct	Sale	28,000	107.52	$3,010,560.00	121,152	4
2025-05-15	Dickinson, Andrew D	Officer	Chief Financial Officer	Direct	Sale	2,500	99.82	$249,550.00	165,674	4
2025-04-15	Dickinson, Andrew D	Officer	Chief Financial Officer	Direct	Sale	2,500	106.40	$266,000.00	168,174	4
2025-03-17	Dickinson, Andrew D	Officer	Chief Financial Officer	Direct	Sale	2,500	110.53	$276,325.00	170,674	4
2025-03-10	Dickinson, Andrew D	Officer	Chief Financial Officer	Direct	Sale	17,929	117.90	$2,113,829.10	169,061	4
2025-02-18	Dickinson, Andrew D	Officer	Chief Financial Officer	Direct	Sale	2,500	104.09	$260,225.00	169,061	4
2025-02-12	Dickinson, Andrew D	Officer	Chief Financial Officer	Direct	Sale	137,676	102.22	$14,073,240.72	171,223	4
2025-01-31	Dickinson, Andrew D	Officer	Chief Financial Officer	Direct	Sale	142,180	97.22	$13,822,739.60	129,873	4
2025-01-15	Dickinson, Andrew D	Officer	Chief Financial Officer	Direct	Sale	2,500	91.35	$228,375.00	129,873	4
2024-12-16	Dickinson, Andrew D	Officer	Chief Financial Officer	Direct	Sale	8,500	91.96	$781,660.00	132,373	4
2024-11-29	Dickinson, Andrew D	Officer	Chief Financial Officer	Direct	Sale	248,645	92.76	$23,064,310.20	138,919	4
2024-11-27	Parsey, Merdad	Officer	Chief Medical Officer	Direct	Sale	164,211	91.88	$15,087,706.68	80,801	4
2024-11-26	Bluestone, Jeffrey	Director	-	Direct	Sale	6,788	91.39	$620,355.32	8,920	4
2024-11-06	Parsey, Merdad	Officer	Chief Medical Officer	Direct	Sale	25,590	91.50	$2,341,485.00	99,599	4
2024-11-06	Mercier, Johanna	Officer	Chief Commercial Officer	Direct	Sale	5,000	91.28	$456,400.00	73,127	4
2024-10-01	Parsey, Merdad	Officer	Chief Medical Officer	Direct	Sale	2,000	83.83	$167,660.00	100,189	4
2024-09-12	Parsey, Merdad	Officer	Chief Medical Officer	Direct	Sale	21,246	84.50	$1,795,287.00	102,189	4
2024-09-12	Mercier, Johanna	Officer	Chief Commercial Officer	Direct	Sale	29,357	83.74	$2,458,355.18	78,127	4
2024-08-28	Mercier, Johanna	Officer	Chief Commercial Officer	Direct	Sale	9,513	78.03	$742,299.39	105,466	4
2024-08-13	Mercier, Johanna	Officer	Chief Commercial Officer	Direct	Sale	5,490	73.98	$406,150.20	114,979	4
2024-07-01	Parsey, Merdad	Officer	Chief Medical Officer	Direct	Sale	2,000	68.63	$137,260.00	96,380	4
2024-04-01	Parsey, Merdad	Officer	Chief Medical Officer	Direct	Sale	2,000	72.96	$145,920.00	96,304	4
2024-02-29	Parsey, Merdad	Officer	Chief Medical Officer	Direct	Sale	8,230	72.74	$598,650.20	92,706	4
2024-01-16	Dickinson, Andrew D	Officer	Chief Financial Officer	Direct	Sale	5,000	85.78	$428,900.00	101,534	4
2024-01-09	Mercier, Johanna	Officer	Chief Commercial Officer	Direct	Sale	8,242	85.23	$702,465.66	82,729	4
2023-10-17	Dickinson, Andrew D	Officer	Chief Financial Officer	Direct	Sale	5,000	80.00	$400,000.00	104,003	4
2023-09-12	Parsey, Merdad	Officer	Chief Medical Officer	Direct	Sale	1,501	76.99	$115,561.99	70,130	4
2023-07-20	Dickinson, Andrew D	Officer	Chief Financial Officer	Direct	Sale	5,000	80.00	$400,000.00	107,587	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

78.36%

Inst. Shares: 973,233,293

Shares Outstanding: 1,242,000,000

2025-12-31

82.26%

Inst. Shares: 1,023,281,544

Shares Outstanding: 1,244,000,000

2025-09-30

80.21%

Inst. Shares: 996,963,440

Shares Outstanding: 1,243,000,000

2025-06-30

81.16%

Inst. Shares: 1,010,498,017

Shares Outstanding: 1,245,000,000

2025-03-31

78.95%

Inst. Shares: 983,680,226

Shares Outstanding: 1,246,000,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	973,233,293	1,242,000,000	78.36%
2025-12-31	1,023,281,544	1,244,000,000	82.26%
2025-09-30	996,963,440	1,243,000,000	80.21%
2025-06-30	1,010,498,017	1,245,000,000	81.16%
2025-03-31	983,680,226	1,246,000,000	78.95%
2024-12-31	1,017,547,206	1,247,000,000	81.60%
2024-09-30	979,988,616	1,247,000,000	78.59%
2024-06-30	983,647,197	1,247,000,000	78.88%
2024-03-31	960,766,387	1,247,000,000	77.05%
2023-12-31	973,841,252	1,248,000,000	78.03%
2023-09-30	955,484,941	1,248,000,000	76.56%
2023-06-30	952,421,688	1,249,000,000	76.25%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

GILEAD SCIENCES, INC. (GILD) — SEC Financial Statements & Analysis

GILEAD SCIENCES, INC. (GILD) is a biological products, (no diagnostic substances) company, incorporated in DE. GILEAD SCIENCES, INC. trades on GILD: Nasdaq as: GILD. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), GILEAD SCIENCES, INC. reported a 3.48% year-over-year revenue growth, a Gross Profit Margin of 79.35% (TTM), a Debt-to-Equity ratio of 0.40x, a Price-to-Sales (P/S) ratio of 5.78x (TTM), a Price-to-Book (P/B) ratio of 7.31 (TTM), at a market cap of $171.97B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 3.48%
Gross Profit Margin TTM: 79.35%
Debt To Equity: 0.40x
P/S TTM: 5.78x
P/B TTM: 7.31
Market Cap: $171.97B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is GILEAD SCIENCES, INC. in?

GILEAD SCIENCES, INC. (GILD) operates in the Biological Products, (No Diagnostic Substances) industry.

What is GILD's market cap?

GILEAD SCIENCES, INC. (GILD) has a market capitalization of $171.97B as of 2026-03-31.

What is GILD's P/E ratio?

GILEAD SCIENCES, INC. (GILD)'s trailing twelve month P/E ratio is 18.66x as of 2026-03-31.

What exchange does GILD trade on?

GILEAD SCIENCES, INC. (GILD) trades on the GILD: Nasdaq.

Where is GILEAD SCIENCES, INC. incorporated?

GILEAD SCIENCES, INC. is incorporated in DE.

GILEAD SCIENCES, INC. (GILD) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.